Both in Pharmaceuticals
Talphera vs Heron Therapeutics
Over the past year TLPH returned −16.9% and HRTX returned −75.6%; their daily moves had a correlation of 0.09.
TLPH −16.9% HRTX −75.6%Growth of $1, one year, split-adjusted
| Metric | TLPH | HRTX |
|---|---|---|
| Price | $1.03 | $0.2777 |
| Market cap | $53.5M | $52.7M |
| Today | −3.74% | −5.67% |
| 1 month | −8.0% | −22.0% |
| 6 months | +12.1% | −78.1% |
| Year to date | −9.6% | −78.6% |
| 1 year | −16.3% | −76.3% |
| Revenue growth (YoY) | — | +1.3% |
| Gross margin | — | 69.3% |
| Net margin | — | −14.6% |
| P/E (TTM) | — | — |
| Price / sales | 53,463.0× | 0.3× |
| Net cash | $17.1M | -$100.0M |
| Dividend yield | — | — |
| Volatility (60d) | 42.8% | 115.7% |
| Short % of float | 4.1% | 25.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).